152 related articles for article (PubMed ID: 11339288)
21. HPLC/MS determination of buprenorphine and norbuprenorphine in biological fluids and hair samples.
Tracqui A; Kintz P; Mangin P
J Forensic Sci; 1997 Jan; 42(1):111-4. PubMed ID: 8988582
[TBL] [Abstract][Full Text] [Related]
22. Investigation of buprenorphine-related deaths using urinary metabolite concentrations.
Mariottini C; Kriikku P; Ojanperä I
Drug Test Anal; 2022 Oct; 14(10):1696-1702. PubMed ID: 35834288
[TBL] [Abstract][Full Text] [Related]
23. A sensitive, simple and rapid HPLC-MS/MS method for simultaneous quantification of buprenorpine and its N-dealkylated metabolite norbuprenorphine in human plasma.
Wang YY; Shen XH; Li H; Chen FJ; Fu Y; Ding L
J Pharm Anal; 2013 Aug; 3(4):221-228. PubMed ID: 29403821
[TBL] [Abstract][Full Text] [Related]
24. A liquid chromatographic-electrospray ionization-tandem mass spectrometric method for determination of buprenorphine, its metabolite, norbuprenorphine, and a coformulant, naloxone, that is suitable for in vivo and in vitro metabolism studies.
Moody DE; Slawson MH; Strain EC; Laycock JD; Spanbauer AC; Foltz RL
Anal Biochem; 2002 Jul; 306(1):31-9. PubMed ID: 12069411
[TBL] [Abstract][Full Text] [Related]
25. Comparison of nonhydrolysis and hydrolysis methods for the determination of buprenorphine metabolites in urine by liquid chromatography-tandem mass spectrometry.
Al-Asmari AI; Anderson RA
J Anal Toxicol; 2008; 32(9):744-53. PubMed ID: 19021929
[TBL] [Abstract][Full Text] [Related]
26. Simultaneous determination of buprenorphine and norbuprenorphine in serum by high-performance liquid chromatography-electrospray ionization-mass spectrometry.
Scislowski M; Piekoszewski W; Kamenczak A; Florek E
J Anal Toxicol; 2005; 29(4):249-53. PubMed ID: 15975254
[TBL] [Abstract][Full Text] [Related]
27. Quantitation of Buprenorphine, Norbuprenorphine, Buprenorphine Glucuronide, Norbuprenorphine Glucuronide, and Naloxone in Urine by LC-MS/MS.
Marin SJ; McMillin GA
Methods Mol Biol; 2016; 1383():69-78. PubMed ID: 26660175
[TBL] [Abstract][Full Text] [Related]
28. Buprenorphine and norbuprenorphine findings in hair during constant maintenance dosage.
Skopp G; Kniest A; Haisser J; Mann K; Hermann D
Int J Legal Med; 2011 Mar; 125(2):277-81. PubMed ID: 21301858
[TBL] [Abstract][Full Text] [Related]
29. Liquid chromatographic-electrospray ionization mass spectrometric quantitative analysis of buprenorphine, norbuprenorphine, nordiazepam and oxazepam in rat plasma.
Pirnay S; Hervé F; Bouchonnet S; Perrin B; Baud FJ; Ricordel I
J Pharm Biomed Anal; 2006 Jun; 41(4):1135-45. PubMed ID: 16554136
[TBL] [Abstract][Full Text] [Related]
30. Buprenorphine assay and plasma concentration monitoring in HIV-infected substance users.
DiFrancesco R; Fischl MA; Donnelly J; Zingman BS; McCance-Katz EF; Moody DE; Reichman RC; Gripshover B; Morse GD
J Pharm Biomed Anal; 2007 May; 44(1):188-95. PubMed ID: 17391891
[TBL] [Abstract][Full Text] [Related]
31. Determination of buprenorphine, naloxone and phase I and phase II metabolites in rat whole blood by LC-MS/MS.
Cohier C; Salle S; Fontova A; Mégarbane B; Roussel O
J Pharm Biomed Anal; 2020 Feb; 180():113042. PubMed ID: 31865207
[TBL] [Abstract][Full Text] [Related]
32. Buprenorphine and nor-buprenorphine levels in head hair samples from former heroin users under Suboxone® treatment.
Belivanis S; Tzatzarakis MN; Vakonaki E; Kovatsi L; Mantsi M; Alegakis A; Kavvalakis MP; Vynias D; Tsatsakis AM
Drug Test Anal; 2014 Jun; 6 Suppl 1():93-100. PubMed ID: 24817054
[TBL] [Abstract][Full Text] [Related]
33. Preliminary buprenorphine sublingual tablet pharmacokinetic data in plasma, oral fluid, and sweat during treatment of opioid-dependent pregnant women.
Concheiro M; Jones HE; Johnson RE; Choo R; Huestis MA
Ther Drug Monit; 2011 Oct; 33(5):619-26. PubMed ID: 21860340
[TBL] [Abstract][Full Text] [Related]
34. Urinary excretion of buprenorphine, norbuprenorphine, buprenorphine-glucuronide, and norbuprenorphine-glucuronide in pregnant women receiving buprenorphine maintenance treatment.
Kacinko SL; Jones HE; Johnson RE; Choo RE; Concheiro-Guisan M; Huestis MA
Clin Chem; 2009 Jun; 55(6):1177-87. PubMed ID: 19325013
[TBL] [Abstract][Full Text] [Related]
35. Simultaneous assay of buprenorphine and norbuprenorphine by negative chemical ionization tandem mass spectrometry.
Kuhlman JJ; Magluilo J; Cone E; Levine B
J Anal Toxicol; 1996; 20(4):229-35. PubMed ID: 8835660
[TBL] [Abstract][Full Text] [Related]
36. Determination of buprenorphine and norbuprenorphine in whole blood by liquid chromatography-mass spectrometry.
Hoja H; Marquet P; Verneuil B; Lotfi H; Dupuy JL; Lachâtre G
J Anal Toxicol; 1997; 21(2):160-5. PubMed ID: 9083835
[TBL] [Abstract][Full Text] [Related]
37. Quantitative determination of buprenorphine, naloxone and their metabolites in rat plasma using hydrophilic interaction liquid chromatography coupled with tandem mass spectrometry.
Joshi A; Parris B; Liu Y; Heidbreder C; Gerk PM; Halquist M
Biomed Chromatogr; 2017 Feb; 31(2):. PubMed ID: 27390058
[TBL] [Abstract][Full Text] [Related]
38. Development and validation of a sensitive analytical method for the simultaneous determination of buprenorphine and norbuprenorphine in human plasma.
Gopal S; Tzeng TB; Cowan A
Eur J Pharm Biopharm; 2001 Mar; 51(2):147-51. PubMed ID: 11226822
[TBL] [Abstract][Full Text] [Related]
39. Hollow fiber liquid-phase microextraction combined with ultra-high performance liquid chromatography-tandem mass spectrometry for the simultaneous determination of naloxone, buprenorphine and norbuprenorphine in human plasma.
Sun W; Qu S; Du Z
J Chromatogr B Analyt Technol Biomed Life Sci; 2014 Mar; 951-952():157-63. PubMed ID: 24566267
[TBL] [Abstract][Full Text] [Related]
40. Buprenorphine and norbuprenorphine determination in mice plasma and brain by gas chromatography-mass spectrometry.
Chiadmi F; Schlatter J
Anal Chem Insights; 2014; 9():9-16. PubMed ID: 24653644
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
